Drug Approval | July 08, 2022
Lupin’s Somerset manufacturing plant Receives EIR from US FDA
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
The curriculum has been curated for General Physicians working in Clinikk
As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs
Subscribe To Our Newsletter & Stay Updated
